/
Metabolic & Endocrine
394Diseases↗
4.1KPipeline Programs↗
1.3KActive Trials↗
Momentum Score:100/100
Landscape
Disease Coverage Map
Bubble size = actively recruiting trials · Click to explore
Analysis
Phase Distribution
Analysis
Trial Status
7,824
clinical trials
Completed5,058 · 65%
Unknown status686 · 9%
Recruiting680 · 9%
Terminated515 · 7%
Not yet recruiting296 · 4%
Active, not recruiting269 · 3%
Other320 · 4%
Competitive
Top Companies Companies ranked by number of pipeline programs they run in this therapeutic area.
95programs
94programs
93programs
89programs
83programs
Landscape
Diseases
Type 2 Diabetes
Most programs710
Programs
303
Trials
79
Recruiting
Pre
117
P1
112
P2
208
P3
199
Appr
250
Most programs:
Eli Lilly
Eli LillyType 2 Diabetes Mellitus
Most trials579
Programs
255
Trials
34
Recruiting
Pre
72
P1
116
P2
169
P3
159
Appr
161
Most programs:
Sanofi
SanofiDiabetes
Highest activity0
Programs
542
Trials
17
Recruiting
Pre
—
P1
1
P2
1
P3
—
Appr
2
Most programs:
Chiesi Farmaceutici S.p.A.
Chiesi Farmaceutici S.p.A.Type 1 Diabetes
9302 programs138 trialsApproved
Diabetes Mellitus
10238 programs131 trialsApproved
Type 1 Diabetes Mellitus
10207 programs124 trialsApproved
Metabolic Syndrome
161 programs21 trialsApproved
Diabetic Foot
2148 programs31 trialsApproved
Polycystic Ovary Syndrome
2140 programs20 trialsApproved
Insulin Resistance
3136 programs18 trialsApproved
Hypercholesterolemia
4105 programs33 trialsApproved
Non-Alcoholic Steatohepatitis
185 programs38 trialsApproved
Hyperlipidemia
181 programs11 trialsApproved
Hypoglycemia
165 programs9 trialsApproved
Hypertriglyceridemia
55 programs15 trialsApproved
Hyperglycemia
258 programs7 trialsApproved
Growth Hormone Deficiency
448 programs14 trialsApproved
Gestational Diabetes
243 programs17 trialsApproved
Obesity or Overweight
10 programs58 trialsPhase 3
Morbid Obesity
153 programs2 trialsApproved
Familial Hypercholesterolemia
137 programs18 trialsApproved
Prader-Willi Syndrome
42 programs11 trialsApproved
Hypothyroidism
135 programs17 trialsApproved
Hyperuricemia
39 programs8 trialsApproved
Hypoparathyroidism
232 programs13 trialsApproved
Mucopolysaccharidosis
133 programs11 trialsApproved
Hypogonadism
36 programs4 trialsApproved
Overweight or Obesity
40 programs40 trialsPhase 2
Secondary Hyperparathyroidism
33 programs5 trialsApproved
Congenital Adrenal Hyperplasia
227 programs8 trialsApproved
Showing top 30 diseases by activity. 364 more diseases in this therapeutic area.Activity = a momentum score from recent trial starts, number of sponsoring companies, and total trial volume.
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)